Table 8.
Frequency of PRO questionnaire administration.
| PRO QUESTIONNAIRE | DAILY | WEEKLY | EVERY 2 WEEKS | EVERY 3 WEEKS | EVERY 4 WEEKS | EVERY 6 WEEKS | EVERY 8 WEEKS | EVERY 9 WEEKS | EVERY 12 WEEKS | AFTER 24 WEEKS | EVERY 36 WEEKS | AFTER 56 WEEKS | AFTER 124 WEEKS | AFTER 136 WEEKS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FACT-B | ✓✓ | ✓✓ | ✓✓ | ✓ | ✓✓✓ | ✓ | ||||||||
| EORTC QLQ-C30 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||
| EQ-5D health status | ✓ | |||||||||||||
| EORTC QLQ-BR23 | ✓ | ✓ | ✓ | |||||||||||
| BPI | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||
| FACT-G | ✓ | ✓ | ✓✓✓ | |||||||||||
| MDASI | ✓ | ✓ | ||||||||||||
| HADS | ✓ | |||||||||||||
| RSCL* | ||||||||||||||
| EQ-5D-5L | ✓ | ✓ | ✓ | |||||||||||
| FACIT-F | ✓ | |||||||||||||
| FACT-ES | ✓ | ✓ | ✓ | |||||||||||
| MAF | ✓ | ✓ | ||||||||||||
| PSQI | ✓ | |||||||||||||
| SF-36 | ✓ | |||||||||||||
| SPHERE | ✓ | |||||||||||||
| SSQ* |
Notes:
*
Frequency of administration data not reported for these PROs. Pindicates one clinical trial with this frequency of administration.